F. Agosta, A. Al-chalabi, M. Filippi, O. Hardiman, R. Kaji et al., The el escorial criteria: strengths and weaknesses, Amyotroph. Lateral Scler. Frontotemporal Degener, vol.16, pp.1-7, 2014.

F. Agosta, E. Pagani, M. Petrolini, D. Caputo, M. Perini et al., Assessment of white matter tract damage in patients with amyotrophic lateral sclerosis: a diffusion tensor MR imaging tractography study: Fig 1, Am. J. Neuroradiol, vol.31, pp.1457-1461, 2010.

F. Agosta, E. G. Spinelli, and M. Filippi, Neuroimaging in amyotrophic lateral sclerosis: current and emerging uses, Expert Rev. Neurother, vol.18, pp.395-406, 2018.

F. Agosta, E. G. Spinelli, I. V. Marjanovic, Z. Stevic, E. Pagani et al., Unraveling ALS due toSOD1mutation through the combination of brain and cervical cord MRI, Neurology, vol.90, pp.707-716, 2018.

D. W. Aha, D. Kibler, A. , and M. K. , Instance-based learning algorithms, Mach. Learn, vol.6, pp.37-66, 1991.

A. Al-chalabi, O. Hardiman, M. C. Kiernan, A. Chiò, B. Rix-brooks et al., Amyotrophic lateral sclerosis: moving towards a new classification system, Lancet Neurol, vol.15, issue.16, pp.30199-30204, 2016.

F. Amato, A. López, E. M. Peña-méndez, P. Va?hara, A. Hampl et al., Artificial neural networks in medical diagnosis, J. Appl. Biomed, vol.11, pp.47-58, 2013.

V. Appel, S. S. Stewart, G. Smith, and S. H. Appel, A rating scale for amyotrophic lateral sclerosis: description and preliminary experience, Ann. Neurol, vol.22, pp.328-333, 1987.

K. C. Arthur, A. Calvo, T. R. Price, J. T. Geiger, A. Chiò et al., Projected increase in amyotrophic lateral sclerosis from 2015 to 2040, Nat. Commun, vol.7, p.12408, 2016.

N. Atassi, J. Berry, A. Shui, N. Zach, A. Sherman et al., The PRO-ACT database: design, initial analyses, and predictive features, Neurology, vol.83, pp.1719-1725, 2014.

J. I. Ayers, S. E. Fromholt, V. M. O'neal, J. H. Diamond, and D. R. Borchelt, Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways, Acta Neuropathol, vol.131, pp.103-114, 2015.

N. Bakkar, T. Kovalik, I. Lorenzini, S. Spangler, A. Lacoste et al., Artificial intelligence in neurodegenerative disease research: use of IBM watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis, Acta Neuropathol, vol.135, pp.227-247, 2017.

R. Balendra, A. Jones, N. Jivraj, C. Knights, C. M. Ellis et al., Estimating clinical stage of amyotrophic lateral sclerosis from the ALS functional rating scale, Amyotroph. Lateral Scler. Frontotemporal Degener, vol.15, pp.279-284, 2014.

R. Balendra, A. Jones, N. Jivraj, I. N. Steen, C. A. Young et al., Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials, J. Neurol. Neurosurg. Psychiatry, vol.86, pp.45-49, 2014.

A. Bandini, J. R. Green, J. Wang, T. F. Campbell, L. Zinman et al., Kinematic features of jaw and lips distinguish symptomatic from presymptomatic stages of bulbar decline in amyotrophic lateral sclerosis, J. Speech Lang. Hear. Res, vol.61, p.1118, 2018.

M. Batyrbekova, T. Prell, B. Stubendorff, R. Steinbach, and M. Bokemeyer, P48. progression of cerebellar involvement in amyotrophic lateral sclerosis as seen by SUIT/ CAT12 voxel-based morphometry and d50 disease modelling, Clin. Neurophysiol, vol.129, pp.86-87, 2018.

K. Baudi, N. Brodu, J. Rusz, and J. Klempir, Objective discrimination between progressive supranuclear palsy and multiple system atrophy using speech analysis, 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2016.

B. K. Beaulieu-jones and C. S. Greene, Semi-supervised learning of the electronic health record for phenotype stratification, J. Biomed. Informatics, vol.64, pp.168-178, 2016.

P. Bede, From qualitative radiological cues to machine learning: MRI-based diagnosis in neurodegeneration, Future Neurol, vol.12, pp.5-8, 2017.

P. Bede, A. Bokde, M. Elamin, S. Byrne, R. L. Mclaughlin et al., Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality, J. Neurol. Neurosurg. Psychiatry, vol.84, pp.766-773, 2012.

P. Bede, A. L. Bokde, S. Byrne, M. Elamin, R. L. Mclaughlin et al., Multiparametric MRI study of ALS stratified for the c9orf72 genotype, Neurology, vol.81, pp.361-369, 2013.

P. Bede, M. Elamin, S. Byrne, and O. Hardiman, Sexual dimorphism in ALS: exploring gender-specific neuroimaging signatures, Amyotroph. Lateral Scler. Frontotemporal Degener, vol.15, pp.235-243, 2013.

P. Bede, M. Elamin, S. Byrne, R. L. Mclaughlin, K. Kenna et al., Basal ganglia involvement in amyotrophic lateral sclerosis, Neurology, vol.81, pp.2107-2115, 2013.

P. Bede, M. Elamin, S. Byrne, R. L. Mclaughlin, K. Kenna et al., Patterns of cerebral and cerebellar white matter degeneration in ALS: Figure 1, J. Neurol. Neurosurg. Psychiatry, vol.86, pp.468-470, 2014.

P. Bede and O. Hardiman, Longitudinal structural changes in ALS: a three time-point imaging study of white and gray matter degeneration, Amyotroph. Lateral Scler. Frontotemporal Degener, vol.19, pp.232-241, 2017.

P. Bede, P. M. Iyer, E. Finegan, T. Omer, and O. Hardiman, Virtual brain biopsies in amyotrophic lateral sclerosis: diagnostic classification based on in vivo pathological patterns, Neuroimage Clin, vol.15, pp.653-658, 2017.

P. Bede, P. M. Iyer, C. Schuster, M. Elamin, R. L. Mclaughlin et al., The selective anatomical vulnerability of ALS: 'disease-defining' and 'disease-defying' brain regions, Amyotroph. Lateral Scler. Frontotemporal Degener, vol.17, pp.561-570, 2016.

P. Bede, T. Omer, E. Finegan, R. H. Chipika, P. M. Iyer et al., Connectivity-based characterisation of subcortical grey matter pathology in frontotemporal dementia and ALS: a multimodal neuroimaging study, Brain Imaging Behav, vol.12, pp.1696-1707, 2018.

P. Bede, G. Querin, and P. Pradat, The changing landscape of motor neuron disease imaging, Curr. Opin. Neurol, vol.31, pp.431-438, 2018.

C. M. Bishop, Pattern Recognition and Machine Learning, 2016.

M. E. Bozik, H. Mitsumoto, B. R. Brooks, S. A. Rudnicki, D. H. Moore et al., A post-hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS, Amyotroph. Lateral Scler. Frontotemporal Degener, vol.15, pp.406-413, 2014.

L. Breiman, Random forests, Mach. Learn, vol.45, pp.5-32, 2001.

J. Brettschneider, A. Petzold, S. D. Sussmuth, A. C. Ludolph, and H. Tumani, Axonal damage markers in cerebrospinal fluid are increased in ALS, Neurology, vol.66, pp.852-856, 2006.

B. R. Brooks, El escorial world federation of neurology criteria for the diagnosis of amyotrophic lateral sclerosis, J. Neurol. Sci, vol.124, pp.96-107, 1994.

B. R. Brooks, R. G. Miller, M. Swash, and T. L. Munsat, El escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis, Amyotroph. Lateral Scler. Other Motor Neuron Disord, vol.1, pp.293-299, 2000.

T. Burke, M. Elamin, M. Galvin, O. Hardiman, and N. Pender, Caregiver burden in amyotrophic lateral sclerosis: a cross-sectional investigation of predictors, J. Neurol, vol.262, pp.1526-1532, 2015.

T. Burke, M. Pinto-grau, K. Lonergan, P. Bede, M. Sullivan et al., A cross-sectional population-based investigation into behavioral change in amyotrophic lateral sclerosis: subphenotypes, staging, cognitive predictors, and survival, Ann. Clin. Transl. Neurol, vol.4, pp.305-317, 2017.

S. Byrne, M. Elamin, P. Bede, A. Shatunov, C. Walsh et al., Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a c9orf72 repeat expansion: a population-based cohort study, Lancet Neurol, vol.11, pp.232-240, 2012.

J. M. Cedarbaum, N. Stambler, E. Malta, C. Fuller, D. Hilt et al., The ALSFRS-r: a revised ALS functional rating scale that incorporates assessments of respiratory function, J. Neurol. Sci, vol.169, pp.13-21, 1999.

E. Cellura, R. Spataro, A. C. Taiello, and V. L. Bella, Factors affecting the diagnostic delay in amyotrophic lateral sclerosis, Clin. Neurol. Neurosurg, vol.114, pp.550-554, 2012.

H. Chen, C. Huang, X. Yu, X. Xu, X. Sun et al., An efficient diagnosis system for detection of parkinson's disease using fuzzy k-nearest neighbor approach, Expert Syst. Appl, vol.40, pp.263-271, 2013.

A. Chio, A. Canosa, S. Gallo, S. Cammarosano, C. Moglia et al., ALS clinical trials: do enrolled patients accurately represent the ALS population, Neurology, vol.77, pp.1432-1437, 2011.

A. Chiò, E. R. Hammond, G. Mora, V. Bonito, and G. Filippini, Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis, J. Neurol. Neurosurg. Psychiatry, vol.86, pp.38-44, 2013.

A. Chiò, G. Logroscino, O. Hardiman, R. Swingler, D. Mitchell et al., Prognostic factors in ALS: a critical review, Amyotroph. Lateral Scler, vol.10, pp.310-323, 2009.

A. Chiò, G. Logroscino, B. Traynor, J. Collins, J. Simeone et al., Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature, Neuroepidemiology, vol.41, pp.118-130, 2013.

A. Chio, G. Mora, A. Calvo, L. Mazzini, E. Bottacchi et al., Epidemiology of ALS in italy: a 10-year prospective population-based study, Neurology, vol.72, pp.725-731, 2009.

E. Choi, S. Biswal, B. Malin, J. Duke, W. F. Stewart et al., Generating multi-label discrete patient records using generative adversarial networks, Proceedings of Machine Learning Research, PMLR, vol.68, 2017.

F. Christidi, E. Karavasilis, I. Zalonis, P. Ferentinos, Z. Giavri et al., Memory-related white matter tract integrity in amyotrophic lateral sclerosis: an advanced neuroimaging and neuropsychological study, Neurobiol. Aging, vol.49, pp.69-78, 2017.

E. A. Coon, E. J. Sorenson, J. L. Whitwell, D. S. Knopman, and K. A. Josephs, Predicting survival in frontotemporal dementia with motor neuron disease, Neurology, vol.76, pp.1886-1892, 2011.

A. F. Costa, M. S. Santos, J. P. Soares, and P. H. Abreu, Missing data imputation via denoising autoencoders: the untold story, Advances in Intelligent Data Analysis XVII, pp.87-98, 2018.

S. R. Cox, D. A. Dickie, S. J. Ritchie, S. Karama, A. Pattie et al., Associations between education and brain structure at age 73 years, adjusted for age 11 IQ, Neurology, vol.87, pp.1820-1826, 2016.

H. Creemers, H. Grupstra, F. Nollet, . Van-den, L. H. Berg et al., Prognostic factors for the course of functional status of patients with ALS: a systematic review, J. Neurol, vol.262, pp.1407-1423, 2014.

A. Davoli, V. Greco, A. Spalloni, E. Guatteo, C. Neri et al., Evidence of hydrogen sulfide involvement in amyotrophic lateral sclerosis, 2015.

, Ann. Neurol, vol.77, pp.697-709

M. De-carvalho, R. Dengler, A. Eisen, J. D. England, R. Kaji et al., Electrodiagnostic criteria for diagnosis of ALS, Clin. Neurophysiol, vol.119, pp.497-503, 2008.

R. De-luis-garcía, C. Westin, and C. Alberola-lópez, Gaussian mixtures on tensor fields for segmentation: applications to medical imaging, Comput. Med. Imaging Graph, vol.35, pp.16-30, 2011.

J. P. Berg, S. Kalmijn, E. Lindeman, J. H. Veldink, M. Visser et al., Multidisciplinary ALS care improves quality of life in patients with ALS, Neurology, vol.65, pp.1264-1267, 2005.

T. Dharmadasa, J. M. Matamala, J. Howells, S. Vucic, and M. C. Kiernan, 10. phenotypic variability in motor neuron disease: site of onset and patterns of disease spread, Clin. Neurophysiol, vol.129, pp.4-5, 2018.

L. D'hulst, D. V. Weehaeghe, A. Chiò, A. Calvo, C. Moglia et al., Multicenter validation of [18f]-FDG PET and support-vector machine discriminant analysis in automatically classifying patients with amyotrophic lateral sclerosis versus controls, Amyotroph. Lateral Scler. Frontotemporal Degener, 2018.

C. Donaghy, O. O'toole, C. Sheehan, F. Kee, O. Hardiman et al., An all-ireland epidemiological study of MND, Eur. J. Neurol, vol.16, pp.148-153, 1998.

M. Elamin, P. Bede, S. Byrne, N. Jordan, L. Gallagher et al., Cognitive changes predict functional decline in ALS: a population-based longitudinal study, Neurology, vol.80, pp.1590-1597, 2013.

M. Elamin, P. Bede, A. Montuschi, N. Pender, A. Chio et al., Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm, J. Neurol, vol.262, pp.1447-1454, 2015.

M. Elamin, J. Phukan, P. Bede, N. Jordan, S. Byrne et al., Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia, Neurology, vol.76, pp.1263-1269, 2011.

M. Elamin, M. Pinto-grau, T. Burke, P. Bede, J. Rooney et al., Identifying behavioural changes in ALS: validation of the beaumont behavioural inventory (BBI), Amyotroph. Lateral Scler. Frontotemporal Degener, vol.18, pp.68-73, 2016.

M. L. Escorcio-bezerra, A. Abrahao, K. F. Nunes, N. I. Braga, A. S. Oliveira et al., Motor unit number index and neurophysiological index as candidate biomarkers of presymptomatic motor neuron loss in amyotrophic lateral sclerosis, Muscle Nerve, vol.58, pp.204-212, 2018.

A. Esteva, B. Kuprel, R. A. Novoa, J. Ko, S. M. Swetter et al., Dermatologist-level classification of skin cancer with deep neural networks, Nature, vol.542, pp.115-118, 2017.

T. Fang, A. A. Khleifat, J. Meurgey, A. Jones, P. N. Leigh et al., Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study, Lancet Neurol, vol.17, issue.18, pp.30054-30055, 2018.

D. Fathi, B. Mohammadi, R. Dengler, S. Böselt, S. Petri et al., Lower motor neuron involvement in ALS assessed by motor unit number index (MUNIX): long-term changes and reproducibility, Clin. Neurophysiol, vol.127, 1984.

T. Fawcett, Roc graphs: notes and practical considerations for researchers, Mach. Learn, vol.31, pp.1-38, 2004.

D. Ferraro, D. Consonni, N. Fini, A. Fasano, C. D. Giovane et al., Amyotrophic lateral sclerosis: a comparison of two staging systems in a population-based study, Eur. J. Neurol, vol.23, pp.1426-1432, 2016.

P. M. Ferraro, F. Agosta, N. Riva, M. Copetti, E. G. Spinelli et al., Multimodal structural MRI in the diagnosis of motor neuron diseases, Neuroimage Clin, vol.16, pp.240-247, 2017.

N. Filippini, G. Douaud, C. E. Mackay, S. Knight, K. Talbot et al., Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis, Neurology, vol.75, pp.1645-1652, 2010.

I. K. Fodor, A survey of dimension reduction techniques, Center Appl. Sci. Comput. Lawrence Livermore Natl Lab, vol.9, pp.1-18, 2002.

R. B. Forbes, Unexpected decline in survival from amyotrophic lateral sclerosis/motor neurone disease, J. Neurol. Neurosurg. Psychiatry, vol.75, pp.1753-1755, 2004.

M. Fratello, G. Caiazzo, F. Trojsi, A. Russo, G. Tedeschi et al., Multi-view ensemble classification of brain connectivity images for neurodegeneration type discrimination, Neuroinformatics, vol.15, pp.199-213, 2017.

N. Geifman, R. E. Kennedy, L. S. Schneider, I. Buchan, and R. D. Brinton, Data-driven identification of endophenotypes of alzheimer's disease progression: implications for clinical trials and therapeutic interventions, 2018.

, Alzheimers Res. Ther, vol.10, p.4

R. Gomeni and M. Fava, Amyotrophic lateral sclerosis disease progression model, Amyotroph. Lateral Scler. Frontotemporal Degener, vol.15, pp.119-129, 2013.

I. Goodfellow, Y. Bengio, A. Courville, I. Goodfellow, J. Pouget-abadie et al., Generative adversarial nets, Advances in Neural Information Processing Systems, pp.2672-2680, 2014.

P. H. Gordon, B. Cheng, I. B. Katz, H. Mitsumoto, and L. P. Rowland, Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS, Neurology, vol.72, pp.1948-1952, 2009.

S. A. Goutman, Diagnosis and clinical management of amyotrophic lateral sclerosis and other motor neuron disorders, CONTINUUM: Lifelong Learn. Neurol, vol.23, pp.1332-1359, 2017.

M. M. Gresle, Y. Liu, L. F. Dagley, J. Haartsen, F. Pearson et al., Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients, J. Neurol. Neurosurg. Psychiatry, vol.85, pp.1209-1213, 2014.

I. Guyon, M. Nikravesh, S. Gunn, and Z. , Feature Extraction, 2006.

O. Hardiman, A. Al-chalabi, A. Chio, E. M. Corr, G. Logroscino et al., Amyotrophic lateral sclerosis, Nat. Rev. Dis. Primers, vol.3, p.17071, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01784633

T. Hastie, Trees Bagging Random Forests and Boosting, 2003.

T. Hastie, R. Tibshirani, and J. Friedman, The Elements of Statistical Learning, 2009.

J. A. Hayden, D. A. Van-der-windt, J. L. Cartwright, P. Côté, and C. Bombardier, Assessing bias in studies of prognostic factors, Ann. Intern. Med, vol.158, p.280, 2013.

T. Hothorn, J. , and H. H. , RandomForest4life: a random forest for predicting ALS disease progression, Amyotroph. Lateral Scler. Frontotemporal Degener, vol.15, pp.444-452, 2014.

W. T. Hu, H. Seelaar, K. A. Josephs, D. S. Knopman, B. F. Boeve et al., Survival profiles of patients with frontotemporal dementia and motor neuron disease, Arch. Neurol, vol.66, pp.1359-1364, 2009.

Z. Huang, H. Zhang, J. Boss, S. A. Goutman, B. Mukherjee et al., Complete hazard ranking to analyze rightcensored data: an ALS survival study, PLoS Comput. Biol, vol.13, p.1005887, 2017.

Y. Ihara, K. Nobukuni, H. Takata, and T. Hayabara, Oxidative stress and metal content in blood and cerebrospinal fluid of amyotrophic lateral sclerosis patients with and without a cu, zn-superoxide dismutase mutation, Neurol. Res, vol.27, pp.105-108, 2005.

P. Ince, J. Evans, M. Knopp, G. Forster, H. Hamdalla et al., Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS, Neurology, vol.60, pp.1252-1258, 2003.

S. Jahandideh, A. A. Taylor, D. Beaulieu, M. Keymer, L. Meng et al., Longitudinal modeling to predict vital capacity in amyotrophic lateral sclerosis, Amyotroph. Lateral Scler. Frontotemporal Degener, vol.19, pp.294-302, 2017.

H. Jelinek, J. Abawajy, A. Kelarev, M. Chowdhury, and A. Stranieri, Decision trees and multi-level ensemble classifiers for neurological diagnostics, 2014.

. Aust, J. Med. Sci, vol.1, pp.1-12

M. Johnston, L. Earll, M. Giles, R. Mcclenahan, D. Stevens et al., Mood as a predictor of disability and survival in patients newly diagnosed with ALS/MND, Br. J. Health Psychol, vol.4, pp.127-136, 1999.

N. Khoury, F. Attal, Y. Amirat, L. Oukhellou, M. et al., Datadriven based approach to aid parkinson's disease diagnosis, Sensors, vol.19, p.242, 2019.
URL : https://hal.archives-ouvertes.fr/hal-01969993

M. C. Kiernan, Motor neuron disease in 2017: progress towards therapy in motor neuron disease, Nat. Rev. Neurol, vol.14, pp.65-66, 2018.

J. A. Knibb, N. Keren, A. Kulka, P. N. Leigh, S. Martin et al., A clinical tool for predicting survival in ALS, J. Neurol. Neurosurg. Psychiatry, vol.87, pp.1361-1367, 2016.

K. D. Ko, T. El-ghazawi, D. Kim, and H. Morizono, Predicting the severity of motor neuron disease progression using electronic health record data with a cloud computing big data approach, 2014 IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology, pp.1-6, 2014.

A. N. Koki´ckoki´c, Z. Stevi´cstevi´c, S. Stojanovi´cstojanovi´c, D. P. Blagojevi´cblagojevi´c, D. R. Jones et al., Biotransformation of nitric oxide in the cerebrospinal fluid of amyotrophic lateral sclerosis patients, Redox Rep, vol.10, pp.265-270, 2005.

K. Kourou, T. P. Exarchos, K. P. Exarchos, M. V. Karamouzis, and D. I. Fotiadis, Machine learning applications in cancer prognosis and prediction, Comput. Struct. Biotechnol. J, vol.13, pp.8-17, 2015.

R. Küffner, N. Zach, R. Norel, J. Hawe, D. Schoenfeld et al., Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression, Nat. Biotechnol, vol.33, pp.51-57, 2014.

P. Larranaga, B. Calvo, R. Santana, C. Bielza, J. Galdiano et al., Machine learning in bioinformatics, Brief. Bioinformatics, vol.7, pp.86-112, 2006.

J. A. Lee and M. Verleysen, Nonlinear Dimensionality Reduction, 2007.
URL : https://hal.archives-ouvertes.fr/hal-01517215

T. Li, J. Howells, C. Lin, N. Garg, M. Kiernan et al., 8. predicting motor disorders from nerve excitability studies, Clin. Neurophysiol, vol.129, p.4, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02269562

M. W. Libbrecht and W. S. Noble, Machine learning applications in genetics and genomics, Nat. Rev. Genet, vol.16, p.321, 2015.

P. J. Lisboa and A. F. Taktak, The use of artificial neural networks in decision support in cancer: a systematic review, Neural Netw, vol.19, pp.408-415, 2006.

G. Litjens, C. I. Sánchez, N. Timofeeva, M. Hermsen, I. Nagtegaal et al., Deep learning as a tool for increased accuracy and efficiency of histopathological diagnosis, Sci. Rep, vol.6, p.26286, 2016.

R. Little, Missing Data 2e, 2002.

J. M. Lobo, A. Jiménez-valverde, and R. Real, AUC: a misleading measure of the performance of predictive distribution models, Global Ecol. Biogeogr, vol.17, pp.145-151, 2008.

G. Louppe, Understanding random forests: from theory to practice, 2014.

H. Lu, H. Wang, and S. W. Yoon, A dynamic gradient boosting machine using genetic optimizer for practical breast cancer prognosis, Expert Syst. Appl, vol.116, pp.340-350, 2019.

D. Lulé, V. Diekmann, S. Anders, J. Kassubek, A. Kübler et al., Brain responses to emotional stimuli in patients with amyotrophic lateral sclerosis (ALS), J. Neurol, vol.254, pp.519-527, 2007.

J. Machts, K. Loewe, J. Kaufmann, S. Jakubiczka, S. Abdulla et al., Basal ganglia pathology in ALS is associated with neuropsychological deficits, Neurology, vol.85, pp.1301-1309, 2015.

V. Majumder, J. M. Gregory, M. A. Barria, A. Green, and S. Pal, TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis, BMC Neurol, vol.18, p.90, 2018.

K. Marek, D. Jennings, S. Lasch, A. Siderowf, C. Tanner et al., The parkinson progression marker initiative (PPMI), Prog. Neurobiol, vol.95, pp.629-635, 2011.

B. Marin, P. Couratier, S. Arcuti, M. Copetti, A. Fontana et al., Stratification of ALS patients' survival: a population-based study, J. Neurol, vol.263, pp.100-111, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01224246

F. J. Martinez-murcia, J. M. Górriz, J. Ramírez, and A. Ortiz, A structural parametrization of the brain using hidden markov modelsbased paths in alzheimer's disease, Int. J. Neural Syst, vol.26, p.1650024, 2016.

C. Mathé, M. Sagot, T. Schiex, and P. Rouzé, Current methods of gene prediction, their strengths and weaknesses, Nucleic Acids Res, vol.30, pp.4103-4117, 2002.

T. Matuz, N. Birbaumer, M. Hautzinger, and A. Kübler, Psychosocial adjustment to ALS: a longitudinal study, Front. Psychol, vol.6, p.1197, 2015.

R. Menke, M. Proudfoot, K. Talbot, and M. Turner, The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis, Neuroimage Clin, vol.17, pp.953-961, 2018.

R. A. Menke, E. Gray, C. Lu, J. Kuhle, K. Talbot et al., CSF neurofilament light chain reflects corticospinal tract degeneration in ALS, Ann. Clin. Transl. Neurol, vol.2, pp.748-755, 2015.

T. Miller, Explanation in artificial intelligence: insights from the social sciences, 2017.

T. Moon, The expectation-maximization algorithm, IEEE Signal Process. Mag, vol.13, pp.47-60, 1996.

K. G. Moons, D. G. Altman, J. B. Reitsma, J. P. Ioannidis, P. Macaskill et al., Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration, Ann. Intern. Med, vol.162, p.1, 2015.

G. Mora and A. Chiò, Disorders of upper and lower motor neurons, Prognosis of Neurological Diseases, pp.261-272, 2015.

C. Moreau, D. Devos, V. Brunaud-danel, L. Defebvre, T. Perez et al., Elevated IL-6 and TNF-levels in patients with ALS: inflammation or hypoxia, Neurology, vol.65, 1958.

S. G. Mueller, M. W. Weiner, L. J. Thal, R. C. Petersen, C. R. Jack et al., Ways toward an early diagnosis in alzheimer's disease: the alzheimer's disease neuroimaging initiative (ADNI), Alzheimers Dement, vol.1, pp.55-66, 2005.

H. Müller, M. R. Turner, J. Grosskreutz, S. Abrahams, P. Bede et al., A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis, J. Neurol. Neurosurg. Psychiatry, vol.87, pp.570-579, 2016.

. Neals-consortium, Northeastern Amyotrophic Lateral Sclerosis Consortium, 2018.

D. Neary, J. Snowden, and D. Mann, Cognitive change in motor neurone disease/amyotrophic lateral sclerosis (MND/ALS), J. Neurol. Sci, vol.180, pp.15-20, 2000.

F. V. Nelwamondo, S. Mohamed, and T. Marwala, Missing data: a comparison of neural network and expectation maximization techniques, Curr. Sci, vol.93, pp.1514-1521, 2007.

M. Neumann, D. M. Sampathu, L. K. Kwong, A. C. Truax, M. C. Micsenyi et al., Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, Science, vol.314, pp.130-133, 2006.

, Neuroimaging Society in Amyotrophic Lateral Sclerosis, Neuroimaging Society in ALS, 2018.

D. Nie, R. Trullo, J. Lian, C. Petitjean, S. Ruan et al., Medical image synthesis with context-aware generative adversarial networks, Lecture Notes in Computer Science, pp.417-425, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02054406

R. K. Olney, J. Murphy, D. Forshew, E. Garwood, B. L. Miller et al., The effects of executive and behavioral dysfunction on the course of ALS, Neurology, vol.65, pp.1774-1777, 2005.

M. Ong, P. F. Tan, and J. D. Holbrook, Predicting functional decline and survival in amyotrophic lateral sclerosis, PLoS ONE, vol.12, p.174925, 2017.

C. J. Pannucci and E. G. Wilkins, Identifying and avoiding bias in research, Plastic Reconstruct. Surg, vol.126, pp.619-625, 2010.

V. Pestov, An axiomatic approach to intrinsic dimension of a dataset, Neural Netw, vol.21, pp.204-213, 2007.

S. R. Pfohl, R. B. Kim, G. S. Coan, and C. S. Mitchell, Unraveling the complexity of amyotrophic lateral sclerosis survival prediction, Front. Neuroinformatics, vol.12, p.36, 2018.

J. Phukan, M. Elamin, P. Bede, N. Jordan, L. Gallagher et al., The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study, J. Neurol. Neurosurg. Psychiatry, vol.83, pp.102-108, 2011.

T. Prell and J. Grosskreutz, The involvement of the cerebellum in amyotrophic lateral sclerosis, Amyotroph. Lateral Scler. Frontotemporal Degener, vol.14, pp.507-515, 2013.

G. Querin, M. E. Mendili, P. Bede, S. Delphine, T. Lenglet et al., Multimodal spinal cord MRI offers accurate diagnostic classification in ALS, J. Neurol. Neurosurg. Psychiatry, vol.89, pp.1220-1221, 2018.

M. K. Rafiq, E. Lee, M. Bradburn, C. J. Mcdermott, and P. J. Shaw, , 2016.

, Creatine kinase enzyme level correlates positively with serum creatinine and lean body mass, and is a prognostic factor for survival in amyotrophic lateral sclerosis, Eur. J. Neurol, vol.23, pp.1071-1078

C. E. Rasmussen, Gaussian Processes for Machine Learning, 2005.

?. Raudys, Statistical and Neural Classifiers, 2001.

J. Ravits, Focality, stochasticity and neuroanatomic propagation in ALS pathogenesis, Exp. Neurol, vol.262, pp.121-126, 2014.

W. Reniers, M. Schrooten, K. G. Claeys, P. Tilkin, A. D'hondt et al., Prognostic value of clinical and electrodiagnostic parameters at time of diagnosis in patients with amyotrophic lateral sclerosis, Amyotroph. Lateral Scler. Frontotemporal Degener, vol.18, pp.341-350, 2017.

A. E. Renton, A. Chiò, and B. J. Traynor, State of play in amyotrophic lateral sclerosis genetics, Nat. Neurosci, vol.17, pp.17-23, 2013.

J. C. Roche, R. Rojas-garcia, K. M. Scott, W. Scotton, C. E. Ellis et al., A proposed staging system for amyotrophic lateral sclerosis, Brain, vol.135, pp.847-852, 2012.

L. Rokach, Decision forest: twenty years of research, Inform. Fusion, vol.27, pp.111-125, 2016.

P. Rong, Y. Yunusova, J. Wang, and J. R. Green, Predicting early bulbar decline in amyotrophic lateral sclerosis: a speech subsystem approach, Behav. Neurol, pp.1-11, 2015.

J. P. Rooney, A. E. Visser, F. D'ovidio, R. Vermeulen, E. Beghi et al., A case-control study of hormonal exposures as etiologic factors for ALS in women, Neurology, vol.89, pp.1283-1290, 2017.

A. Rosenbohm, R. S. Peter, S. Erhardt, D. Lulé, D. Rothenbacher et al., Epidemiology of amyotrophic lateral sclerosis in southern germany, J. Neurol, vol.264, pp.749-757, 2017.

D. Rossi, P. Volanti, L. Brambilla, T. Colletti, R. Spataro et al., CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis, J. Neurol, vol.265, pp.510-521, 2018.

S. Roweis and Z. Ghahramani, A unifying review of linear gaussian models, Neural Comput, vol.11, pp.305-345, 1999.

D. B. Rubin, Foundations of Multidimensional and Metric Data Structures, 1987.

C. Sammut and G. I. Webb, Encyclopedia of Machine Learning and Data Mining, 2017.

A. Sarica, A. Cerasa, P. Valentino, J. Yeatman, M. Trotta et al., The corticospinal tract profile in amyotrophic lateral sclerosis, Hum. Brain Mapp, vol.38, pp.727-739, 2016.

R. E. Schapire, The boosting approach to machine learning: an overview, Nonlinear Estimation and Classification, pp.149-171, 2003.
DOI : 10.1007/978-0-387-21579-2_9

P. L. Schiffman and J. M. Belsh, Pulmonary function at diagnosis of amyotrophic lateral sclerosis, Chest, vol.103, pp.508-513, 1993.

C. Schuster, M. Elamin, O. Hardiman, and P. Bede, Presymptomatic and longitudinal neuroimaging in neurodegeneration-from snapshots to motion picture: a systematic review, J. Neurol. Neurosurg. Psychiatry, vol.86, pp.1089-1096, 2015.

C. Schuster, M. Elamin, O. Hardiman, and P. Bede, The segmental diffusivity profile of amyotrophic lateral sclerosis associated white matter degeneration, Eur. J. Neurol, vol.23, pp.1361-1371, 2016.

C. Schuster, O. Hardiman, and P. Bede, Development of an automated MRI-based diagnostic protocol for amyotrophic lateral sclerosis using diseasespecific pathognomonic features: a quantitative disease-state classification study, PLoS ONE, vol.11, 2016.

C. Schuster, O. Hardiman, P. ;. Bede, A. Zeileis, and T. Hothorn, Survival prediction in amyotrophic lateral sclerosis based on MRI measures and clinical characteristics, Stat. Methods Med. Res, vol.17, pp.3104-3125, 2017.
DOI : 10.1186/s12883-017-0854-x

URL : https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-017-0854-x

A. B. Shaik and S. Srinivasan, A brief survey on random forest ensembles in classification model, International Conference on Innovative Computing and Communications, pp.253-260, 2018.
DOI : 10.1007/978-981-13-2354-6_27

E. P. Simpson, Y. K. Henry, J. S. Henkel, R. G. Smith, and S. H. Appel, Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden, Neurology, vol.62, pp.1758-1765, 2004.

T. Srivastava, B. T. Darras, J. S. Wu, and S. B. Rutkove, Machine learning algorithms to classify spinal muscular atrophy subtypes, Neurology, vol.79, pp.358-364, 2012.
DOI : 10.1212/wnl.0b013e3182604395

URL : http://europepmc.org/articles/pmc3400094?pdf=render

P. Steinacker, E. Feneberg, J. Weishaupt, J. Brettschneider, H. Tumani et al., Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients, J. Neurol. Neurosurg. Psychiatry, vol.87, pp.12-20, 2015.

M. J. Strong, S. Abrahams, L. H. Goldstein, S. Woolley, P. Mclaughlin et al., Amyotrophic lateral sclerosis -frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria, Amyotroph. Lateral Scler. Frontotemporal Degener, vol.18, pp.153-174, 2017.
DOI : 10.1080/21678421.2016.1267768

URL : https://ueaeprints.uea.ac.uk/62302/1/Accepted_manuscript.pdf

M. J. Strong, G. M. Grace, M. Freedman, C. Lomen-hoerth, S. Woolley et al., Consensus criteria for the diagnosis of frontotemporal cognitive and behaviouralfba syndromes in amyotrophic lateral sclerosis, Amyotroph. Lateral Scler, vol.10, pp.131-146, 2009.

K. Suzuki, Overview of deep learning in medical imaging, Radiol. Phys. Technol, vol.10, pp.257-273, 2017.

S. J. Tabrizi, R. Reilmann, R. A. Roos, A. Durr, B. Leavitt et al., Potential endpoints for clinical trials in premanifest and early huntington's disease in the track-hd study: analysis of 24 month observational data, Lancet Neurol, vol.11, pp.42-53, 2012.

P. Talman, T. Duong, S. Vucic, S. Mathers, S. Venkatesh et al., Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian national motor neuron disease observational cohort, BMJ Open, vol.6, 2016.

A. A. Taylor, C. Fournier, M. Polak, L. Wang, N. Zach et al., Predicting disease progression in amyotrophic lateral sclerosis, Ann. Clin. Transl. Neurol, vol.3, pp.866-875, 2016.

J. P. Taylor, R. H. Brown, C. , and D. W. , Decoding ALS: from genes to mechanism, Nature, vol.539, pp.197-206, 2016.
DOI : 10.1038/nature20413

URL : http://europepmc.org/articles/pmc5585017?pdf=render

N. J. Thakore, B. R. Lapin, T. G. Kinzy, and E. P. Pioro, Deconstructing progression of amyotrophic lateral sclerosis in stages: a markov modeling approach, Amyotroph. Lateral Scler. Frontotemporal Degener, vol.19, pp.483-494, 2018.

H. Tohgi, T. Abe, K. Yamazaki, T. Murata, E. Ishizaki et al., Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis, Ann. Neurol, vol.46, pp.129-131, 1999.

R. Tortelli, M. Copetti, F. Panza, R. Cortese, R. Capozzo et al., Time to generalisation as a predictor of prognosis in amyotrophic lateral sclerosis: Table 1, J. Neurol. Neurosurg. Psychiatry, vol.87, pp.678-679, 2015.

R. Tortelli, M. Copetti, M. Ruggieri, R. Cortese, R. Capozzo et al., Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis, Eur. J. Neurol, vol.22, pp.215-218, 2014.

B. J. Traynor, M. B. Codd, B. Corr, C. Forde, E. Frost et al., Amyotrophic lateral sclerosis mimic syndromes, Arch. Neurol, vol.57, p.109, 2000.

M. R. Turner, Progress and new frontiers in biomarkers for amyotrophic lateral sclerosis, Biomark. Med, vol.12, pp.693-696, 2018.

M. R. Turner, J. Grosskreutz, J. Kassubek, S. Abrahams, F. Agosta et al., Towards a neuroimaging biomarker for amyotrophic lateral sclerosis, Lancet Neurol, vol.10, pp.400-403, 2011.

M. R. Turner, O. Hardiman, M. Benatar, B. R. Brooks, A. Chio et al., Controversies and priorities in amyotrophic lateral sclerosis, Lancet Neurol, vol.12, pp.310-322, 2013.

M. R. Turner, M. C. Kiernan, P. N. Leigh, T. , and K. , Multiple imputation of discrete and continuous data by fully conditional specification, Stat. Methods Med. Res, vol.8, pp.219-242, 2007.

H. K. Van-der-burgh, R. Schmidt, H. Westeneng, M. A. De-reus, . Van-den et al., Deep learning predictions of survival based on MRI in amyotrophic lateral sclerosis, Neuroimage Clin, vol.13, pp.361-369, 2017.

V. N. Vapnik, The Nature of Statistical Learning Theory, 2000.

A. Varghese, A. Sharma, P. Mishra, K. Vijayalakshmi, H. Harsha et al., Chitotriosidase -a putative biomarker for sporadic amyotrophic lateral sclerosis, Clin. Proteomics, vol.10, p.19, 2013.

A. E. Visser, J. P. Rooney, F. D'ovidio, H. Westeneng, R. C. Vermeulen et al., Multicentre, cross-cultural, populationbased, case-control study of physical activity as risk factor for amyotrophic lateral sclerosis, J. Neurol. Neurosurg. Psychiatry, vol.89, pp.797-803, 2018.

J. Visser, R. M. Van-den-berg-vos, H. Franssen, . Van-den, L. H. Berg et al., Disease course and prognostic factors of progressive muscular atrophy, Arch. Neurol, vol.64, p.522, 2007.

S. Wang, J. Peng, J. Ma, and J. Xu, Protein secondary structure prediction using deep convolutional neural fields, Sci. Rep, vol.6, p.18962, 2016.

R. C. Welsh, L. M. Jelsone-swain, and B. R. Foerster, The utility of independent component analysis and machine learning in the identification of the amyotrophic lateral sclerosis diseased brain, Front. Hum. Neurosci, vol.7, p.251, 2013.

H. Westeneng, T. P. Debray, A. E. Visser, R. P. Van-eijk, J. P. Rooney et al., Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model, Lancet Neurol, vol.17, pp.423-433, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01784633

J. Wolf, A. Safer, J. C. Wöhrle, F. Palm, W. A. Nix et al., Factors predicting survival in ALS patients -data from a population-based registry in rhineland-palatinate, germany, Neuroepidemiology, vol.44, pp.149-155, 2015.

P. Zetterström, P. M. Andersen, T. Brännström, and S. L. Marklund, , 2011.

, Misfolded superoxide dismutase-1 in CSF from amyotrophic lateral sclerosis patients, J. Neurochem, vol.117, pp.91-99

F. Zhang, G. Chen, M. He, J. Dai, H. Shang et al., Altered white matter microarchitecture in amyotrophic lateral sclerosis: A voxel-based meta-analysis of diffusion tensor imaging, Neuroimage Clin, vol.19, pp.122-129, 2018.

J. Zhang, K. Ma, M. Er, C. , and V. , Tumor segmentation from magnetic resonance imaging by learning via one-class support vector machine, International Workshop on Advanced Image Technology, 2004.
URL : https://hal.archives-ouvertes.fr/inria-00548532

Y. Zhang, B. Zhang, F. Coenen, J. Xiao, and W. Lu, One-class kernel subspace ensemble for medical image classification, EURASIP J. Adv. Signal Process, p.17, 2014.

J. Zhou, L. Afjehi-sadat, S. Asress, D. M. Duong, M. Cudkowicz et al., Galectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: discovery by a proteomics approach, J. Proteome Res, vol.9, pp.5133-5141, 2010.

S. Zoccolella, E. Beghi, G. Palagano, A. Fraddosio, V. Samarelli et al., Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study, J. Neurol. Sci, vol.250, pp.45-49, 2006.